Turning Point Therapeutics

About:

Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.

Website: http://www.tptherapeutics.com

Twitter/X: TPTherapeutics

Top Investors: OrbiMed, Foresite Capital, Cormorant Asset Management, SR One, Lilly Asia Ventures

Description:

Turning Point Therapeutics is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. They focus on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating the tumor microenvironment and tumor immunity.

Total Funding Amount:

$1.18B

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

San Diego, California, United States

Founded Date:

2013-10-08

Contact Email:

peter.li(AT)tptherapeutics.com

Founders:

J. Jean Cui, Y. Peter Li

Number of Employees:

251-500

Last Funding Date:

2020-10-26

IPO Status:

Delisted

© 2025 bioDAO.ai